High expression of ATAD2 can facilitate the up-regulation of B-MYB 57, while ATAD2 silencing significantly inhibits the expression of B-MYB and some cell cycle proteins, such as cyclin E1, cyclin B1 and cyclin A2 in malignant tumors 76. Here, MYBL2 is linked to cancer.